Literature DB >> 11819687

Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line.

Yong He, Jun Zhou, Jin-Sheng Wu, Ke-Feng Dou.   

Abstract

Entities:  

Year:  2000        PMID： 11819687      PMCID： PMC4688856          DOI： 10.3748/wjg.v6.i5.747

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  30 in total

Review 1.  Antisense inhibition of oncogene expression.

Authors:  L Neckers; L Whitesell; A Rosolen; D A Geselowitz
Journal:  Crit Rev Oncog       Date:  1992

2.  Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.

Authors:  H Masui; T Kawamoto; J D Sato; B Wolf; G Sato; J Mendelsohn
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

3.  Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.

Authors:  N Dean; R McKay; L Miraglia; R Howard; S Cooper; J Giddings; P Nicklin; L Meister; R Ziel; T Geiger; M Muller; D Fabbro
Journal:  Cancer Res       Date:  1996-08-01       Impact factor: 12.701

4.  Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody.

Authors:  X Wu; M Rubin; Z Fan; T DeBlasio; T Soos; A Koff; J Mendelsohn
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

5.  Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.

Authors:  S Cohen; G Carpenter; L King
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat.

Authors:  K Akino; A Ohtsuru; H Yano; S Ozeki; H Namba; M Nakashima; M Ito; T Matsumoto; S Yamashita
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

7.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

8.  Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.

Authors:  T Teramoto; M Onda; A Tokunaga; G Asano
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

9.  Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.

Authors:  J Cerutti; F Trapasso; C Battaglia; L Zhang; M L Martelli; R Visconti; M T Berlingieri; J A Fagin; M Santoro; A Fusco
Journal:  Clin Cancer Res       Date:  1996-01       Impact factor: 12.531

10.  Epidermal growth factor receptors in non-small cell lung cancer.

Authors:  D Veale; T Ashcroft; C Marsh; G J Gibson; A L Harris
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640
View more
  8 in total

1.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells.

Authors:  Wen-Yu Yang; Zong-Hai Huang; Li-Jun Lin; Zhou Li; Jing-Long Yu; Hui-Juan Song; Yong Qian; Xiao-Yan Che
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.

Authors:  Li-Zong Shen; Wen-Xi Wu; De-Hua Xu; Zhong-Cheng Zheng; Xin-Yuan Liu; Qiang Ding; Yi-Bing Hua; Kun Yao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice.

Authors:  Lu Xia; Yao-Zong Yuan; Chun-Di Xu; Yong-Pin Zhang; Ming-Ming Qiao; Jia-Xu Xu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 5.  Early diagnosis for colorectal cancer in China.

Authors:  Ya-Li Zhang; Zhen-Su Zhang; Ba-Ping Wu; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.

Authors:  Jia-Yin Yang; Hua-You Luo; Qi-Yuan Lin; Zi-Ming Liu; Lu-Nan Yan; Ping Lin; Jie Zhang; Shong Lei
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

8.  Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.

Authors:  Shao-Jiang Zheng; Shao-Ping Zheng; Feng-Ying Huang; Chang-Liang Jiao; Ren-Liang Wu
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.